Cargando…

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients

Although there have been many improvements in prognosis for patients with cancer, anticancer therapies are burdened by the risk of cardiovascular toxicity. Heart failure is one of the most dramatic clinical expressions of cardiotoxicity, and it may occur acutely or appear years after treatment. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuomo, Alessandra, Rodolico, Alessio, Galdieri, Amalia, Russo, Michele, Campi, Giacomo, Franco, Riccardo, Bruno, Dalila, Aran, Luisa, Carannante, Antonio, Attanasio, Umberto, Tocchetti, Carlo G, Varricchi, Gilda, Mercurio, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2019
Materias:	Co-Morbidities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545979/ https://www.ncbi.nlm.nih.gov/pubmed/31179022 http://dx.doi.org/10.15420/cfr.2018.32.2

Ejemplares similares

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders
por: Cermakova, Pavla, et al.
Publicado: (2015)

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
por: Knight, Jason S, et al.
Publicado: (2014)

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
por: Urowitz, M B, et al.
Publicado: (2016)

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis
por: Geraldino-Pardilla, Laura, et al.
Publicado: (2016)

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
por: Boulos, Daniel, et al.
Publicado: (2017)

Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography
por: Perel-Winkler, Alexandra, et al.
Publicado: (2018)

Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
por: Uchmanowicz, Izabella, et al.
Publicado: (2019)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
por: Zelniker, Thomas A, et al.
Publicado: (2019)

Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Nicol, Martin, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019)

Antibodies to Chlamydia trachomatis and reproductive health issues in women with SLE: a case–control study
por: Santos, Alba, et al.
Publicado: (2018)

Diet, the Gut Microbiome and Heart Failure
por: Harikrishnan, Sivadasanpillai
Publicado: (2019)

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
por: Spitzer, Ernest, et al.
Publicado: (2019)

High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index
por: Stojan, George, et al.
Publicado: (2020)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019)

Autoantibody clustering of lupus-associated pulmonary hypertension
por: Mizus, Marisa, et al.
Publicado: (2019)

Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
por: Ebner, Nicole, et al.
Publicado: (2019)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Associations of metabolic syndrome in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2020)

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Intracellular homocysteine metabolites in SLE: plasma S-adenosylhomocysteine correlates with coronary plaque burden
por: Stojan, George, et al.
Publicado: (2021)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases
por: Gorodetskiy, Vadim, et al.
Publicado: (2021)

Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus
por: Hasse, Stephan, et al.
Publicado: (2022)

Risk factors for changes in carotid intima media thickness and plaque over 5 years in women with systemic lupus erythematosus
por: Lertratanakul, Apinya, et al.
Publicado: (2021)

Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy—a tertiary centre experience in an Appalachian state
por: McVeigh, Elise Danielle, et al.
Publicado: (2021)

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus
por: Zinglersen, Amanda Hempel, et al.
Publicado: (2021)

Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study
por: Wang, Haiting, et al.
Publicado: (2022)

Impact of severe infections in SLE: an observational study from the Spanish national registry
por: Moreno-Torres, Victor, et al.
Publicado: (2022)

Clinical associations of cognitive dysfunction in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2023)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2023)

Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE
por: Ferrigno, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mf0lejsmolq7dch0lbaj4mu5jj